PCVX
Vaxcyte Inc
Halal Rating :
Last Price
$85.00
Last updated:
Market Cap
-
7D Change
4.72%
1 Year Change
34.39%
Company Overview
Industries
Exchange
Next Earnings Date
Vaxcyte Inc is a clinical-stage vaccine innovation company developing novel vaccines to prevent or treat infectious diseases. The company's lead vaccine candidate, VAX-24, is a 24-valent pneumococcal conjugate vaccine in development for the prevention of invasive pneumococcal disease. The company utilizes its proprietary cell-free protein synthesis platform, XpressCF, to produce complex protein antigens.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Vaxcyte Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.